Measure on innovation efficiency of China's pharmaceutical manufacturing industry

Pharmaceutical manufacturing industry is an important industry to ensure human life safety. The innovation efficiency is a significant factor to stimulate the development of pharmaceutical manufacturing industry. At present, there are few studies on the innovation efficiency of pharmaceutical manufa...

Full description

Bibliographic Details
Main Authors: Shen Zhong, Shuqi Liang, Yuxin Zhong, Yunying Zheng, Fengjun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1024997/full
_version_ 1828097048802492416
author Shen Zhong
Shuqi Liang
Yuxin Zhong
Yunying Zheng
Fengjun Wang
author_facet Shen Zhong
Shuqi Liang
Yuxin Zhong
Yunying Zheng
Fengjun Wang
author_sort Shen Zhong
collection DOAJ
description Pharmaceutical manufacturing industry is an important industry to ensure human life safety. The innovation efficiency is a significant factor to stimulate the development of pharmaceutical manufacturing industry. At present, there are few studies on the innovation efficiency of pharmaceutical manufacturing industry. To fill this gap, this paper estimates the innovation efficiency of China's pharmaceutical manufacturing industry in 23 provinces of China from 2010 to 2020 based on the super-network SBM model and Global-Malmquist index. The results show that: (1) From the perspective of efficiency of research and development stage (ERDS), the ERDS of China shows an increasing trend, with the most prominent growth in the western region. (2) From the perspective of efficiency of economic transformation stage (EETS), although there are fluctuations in the EETS, the overall development is good. The EETS of the central region and western region is better than that of the eastern region. (3) By comparing the efficiency of the two stages, it is found that the change direction of the efficiency of the two stages is not necessarily the same in some provinces.
first_indexed 2024-04-11T07:39:58Z
format Article
id doaj.art-aac75180fc5d4c6fae588f9b9226745b
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-11T07:39:58Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-aac75180fc5d4c6fae588f9b9226745b2022-12-22T04:36:36ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-11-011010.3389/fpubh.2022.10249971024997Measure on innovation efficiency of China's pharmaceutical manufacturing industryShen Zhong0Shuqi Liang1Yuxin Zhong2Yunying Zheng3Fengjun Wang4School of Finance, Harbin University of Commerce, Harbin, Heilongjiang, ChinaSchool of Finance, Harbin University of Commerce, Harbin, Heilongjiang, ChinaDepartment of Neurology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaDepartment of Neurology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaDepartment of Neurology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaPharmaceutical manufacturing industry is an important industry to ensure human life safety. The innovation efficiency is a significant factor to stimulate the development of pharmaceutical manufacturing industry. At present, there are few studies on the innovation efficiency of pharmaceutical manufacturing industry. To fill this gap, this paper estimates the innovation efficiency of China's pharmaceutical manufacturing industry in 23 provinces of China from 2010 to 2020 based on the super-network SBM model and Global-Malmquist index. The results show that: (1) From the perspective of efficiency of research and development stage (ERDS), the ERDS of China shows an increasing trend, with the most prominent growth in the western region. (2) From the perspective of efficiency of economic transformation stage (EETS), although there are fluctuations in the EETS, the overall development is good. The EETS of the central region and western region is better than that of the eastern region. (3) By comparing the efficiency of the two stages, it is found that the change direction of the efficiency of the two stages is not necessarily the same in some provinces.https://www.frontiersin.org/articles/10.3389/fpubh.2022.1024997/fullpharmaceutical manufacturinginnovation efficiencysuper network SBM modelGlobal-Malmquist indexDEA
spellingShingle Shen Zhong
Shuqi Liang
Yuxin Zhong
Yunying Zheng
Fengjun Wang
Measure on innovation efficiency of China's pharmaceutical manufacturing industry
Frontiers in Public Health
pharmaceutical manufacturing
innovation efficiency
super network SBM model
Global-Malmquist index
DEA
title Measure on innovation efficiency of China's pharmaceutical manufacturing industry
title_full Measure on innovation efficiency of China's pharmaceutical manufacturing industry
title_fullStr Measure on innovation efficiency of China's pharmaceutical manufacturing industry
title_full_unstemmed Measure on innovation efficiency of China's pharmaceutical manufacturing industry
title_short Measure on innovation efficiency of China's pharmaceutical manufacturing industry
title_sort measure on innovation efficiency of china s pharmaceutical manufacturing industry
topic pharmaceutical manufacturing
innovation efficiency
super network SBM model
Global-Malmquist index
DEA
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.1024997/full
work_keys_str_mv AT shenzhong measureoninnovationefficiencyofchinaspharmaceuticalmanufacturingindustry
AT shuqiliang measureoninnovationefficiencyofchinaspharmaceuticalmanufacturingindustry
AT yuxinzhong measureoninnovationefficiencyofchinaspharmaceuticalmanufacturingindustry
AT yunyingzheng measureoninnovationefficiencyofchinaspharmaceuticalmanufacturingindustry
AT fengjunwang measureoninnovationefficiencyofchinaspharmaceuticalmanufacturingindustry